These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 20484416)
1. PET/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors? Pfannenberg C; Aschoff P; Dittmann H; Mayer F; Reischl G; von Weyhern C; Kanz L; Claussen CD; Bares R; Hartmann JT J Nucl Med; 2010 Jun; 51(6):845-53. PubMed ID: 20484416 [TBL] [Abstract][Full Text] [Related]
2. 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors. Troost EG; Bussink J; Hoffmann AL; Boerman OC; Oyen WJ; Kaanders JH J Nucl Med; 2010 Jun; 51(6):866-74. PubMed ID: 20484426 [TBL] [Abstract][Full Text] [Related]
3. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG. Tian J; Yang X; Yu L; Chen P; Xin J; Ma L; Feng H; Tan Y; Zhao Z; Wu W J Nucl Med; 2008 Feb; 49(2):186-94. PubMed ID: 18199618 [TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3'deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging. Richard SD; Bencherif B; Edwards RP; Elishaev E; Krivak TC; Mountz JM; DeLoia JA Nucl Med Biol; 2011 May; 38(4):485-91. PubMed ID: 21531285 [TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas. Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821 [TBL] [Abstract][Full Text] [Related]
7. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors]. Wu ZJ; Zhang YX; Wei H; Jia Q Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG-PET/CT in a patient with suspected recurrence of germ cell tumor. Penna D; Arena V; Pelosi E J Cancer Res Ther; 2013; 9(3):520-2. PubMed ID: 24125998 [TBL] [Abstract][Full Text] [Related]
9. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. Du Y; Cullum I; Illidge TM; Ell PJ J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153 [TBL] [Abstract][Full Text] [Related]
10. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries. Schwarz JK; Grigsby PW; Dehdashti F; Delbeke D J Nucl Med; 2009 May; 50 Suppl 1():64S-73S. PubMed ID: 19380409 [TBL] [Abstract][Full Text] [Related]
11. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging. Picchio M; Mangili G; Samanes Gajate AM; De Marzi P; Spinapolice EG; Mapelli P; Giovacchini G; Sigismondi C; Viganò R; Sironi S; Messa C Nucl Med Commun; 2010 Jun; 31(6):506-12. PubMed ID: 20168262 [TBL] [Abstract][Full Text] [Related]
12. Correlation of 18F-FLT uptake with tumor grade and Ki-67 immunohistochemistry in patients with newly diagnosed and recurrent gliomas. Yamamoto Y; Ono Y; Aga F; Kawai N; Kudomi N; Nishiyama Y J Nucl Med; 2012 Dec; 53(12):1911-5. PubMed ID: 23081994 [TBL] [Abstract][Full Text] [Related]
13. Monitoring tumor response to therapy with 18F-FLT PET. Weber WA J Nucl Med; 2010 Jun; 51(6):841-4. PubMed ID: 20484418 [No Abstract] [Full Text] [Related]
14. Adult extragonadal germ cell tumors. Shinagare AB; Jagannathan JP; Ramaiya NH; Hall MN; Van den Abbeele AD AJR Am J Roentgenol; 2010 Oct; 195(4):W274-80. PubMed ID: 20858789 [TBL] [Abstract][Full Text] [Related]
16. Postchemotherapy residual masses in nonseminomatous germ cell tumor patients: 18F-FLT PET is unlikely to identify mature teratoma, but imaging of alphav beta3 integrin expression could. Joly F; Paciencia M; Bor C; Aide N J Nucl Med; 2011 May; 52(5):840. PubMed ID: 21536932 [No Abstract] [Full Text] [Related]
17. Imaging of testicular germ cell tumours. Dalal PU; Sohaib SA; Huddart R Cancer Imaging; 2006 Sep; 6(1):124-34. PubMed ID: 16966068 [TBL] [Abstract][Full Text] [Related]
18. Monitoring tumor response with radiolabeled nucleoside analogs in a hepatoma-bearing mouse model early after doxisome(®) treatment. Wu CY; Chou LS; Chan PC; Ho CH; Lin MH; Shen CC; Liu RS; Lin WJ; Wang HE Mol Imaging Biol; 2013 Jun; 15(3):326-35. PubMed ID: 23247923 [TBL] [Abstract][Full Text] [Related]
19. Abdominal Metastases of Intracranial Germ Cell Tumor Via Ventriculoperitoneal Shunt Detected by 18F-FDG PET/CT. Yang Q; Zhu W; Huo L Clin Nucl Med; 2020 Oct; 45(10):836-837. PubMed ID: 32804759 [TBL] [Abstract][Full Text] [Related]
20. Bone metastasis of a breast cancer detected by 3'-deoxy-3'-18F-fluorothymidine PET/CT. Cochet A; Berriolo-Riedinger A; Girault S; Rousseau C; Brunotte F; Couturier O Nuklearmedizin; 2009; 48(5):N45-6. PubMed ID: 20512194 [No Abstract] [Full Text] [Related] [Next] [New Search]